Why Pain Feels Worse at Night & Disrupts Sleep?
Pain syndromes encompass not only physical and sensory symptoms but also involve emotional and cognitive alterations such as functional impairment, negative affect, feelings of stress, and fatigue. In rodents, chronic inflammatory pain induced by intraplantar injection of Complete Freund's Adjuvant (CFA) leads to anhedonia and disruptions in natural behaviors, similar to uncontrolled stress responses.
Building on this understanding, on June 22, 2025, William A. Carlezon Jr.'s research team at McLean Hospital, USA, published a study in the journal Neuropsychopharmacology titled "Inflammatory pain in mice induces light cycle-dependent effects on sleep architecture." This research reveals that inflammatory pain in mice triggers changes in sleep architecture that are dependent on the light cycle.
Products
At Creative Biolabs, we offer a wide range of products and services to fuel your neuroscience research. Please contact us for more information.
Cat. No | Product Name | Product Types |
---|---|---|
NRYF-0124-HZ120 | NeuroBiologics™ Dorsal Root Ganglia Total RNA of Human: Pain | Biospecimens |
NRYF-0124-HZ1265 | NeuroBiologics™ Dorsal Root Ganglia Frozen Blocks of Human: Pain | Biospecimens |
NRZP-0323-ZP393 | Kenpaullone | Cell Assay Reagents |
Services | Description |
---|---|
Pain Drug Discovery Service | Creative Biolabs is a leading biotechnology company specializing in neuroscience, particularly pain research. We offer comprehensive, customized, one-stop services to clients worldwide, leveraging our advanced experimental platform and expert team. Our services include animal model establishment, targeted drug screening, and drug development for pain-related conditions. |
Overview
The authors investigated whether these similarities also extended to changes in sleep and rhythm, mirroring those induced by chronic social defeat stress. They observed mice using both actigraphy and wireless electroencephalography (EEG). The experiment compared differences between groups of mice that received injections at the beginning of either the light or dark cycle.
The authors discovered that CFA-induced inflammatory pain altered the sleep architecture in both male and female mice. Most notably, during the dark phase (when mice are typically more awake), total sleep time increased, accompanied by longer sleep bouts and shorter wake bouts. Conversely, during the light phase, sleep bouts shortened, indicating more fragmented sleep. Similarly, CFA-induced increases in the duration and number of Rapid Eye Movement (REM) sleep and Slow-Wave Sleep (SWS) predominantly occurred during the dark phase. These dark-phase effects were highly consistent in mice injected either at the beginning of the dark cycle or 12 hours prior, whereas the light-phase effects were more dependent on the time elapsed since injection. Furthermore, the injection also led to non-specific alterations in circadian rhythmicity.
The authors' findings suggest that inflammatory pain significantly increases sleep during the normally active phase and impacts the transitions between sleep and wakefulness throughout the entire day.
Findings of the Study
In summary, the authors found that inflammatory pain significantly increased sleep during the normally active phase and altered the transitions between sleep and wakefulness throughout the entire day. This research not only elucidates the complex effects of inflammatory pain on sleep architecture but also highlights the crucial role of circadian rhythms in this process. It provides an important animal model and mechanistic clues for studying the interaction between pain and sleep, while also laying the groundwork for future clinical translation and the optimization of therapeutic strategies.
Disclaimer: Please note that we do not provide the content above, nor do we hold copyright to it. This article is for informational and knowledge-sharing purposes only and does not constitute an offer of commercial services related to its subject matter.
Resources
Reference
- Burek, Dominika J et al. "Inflammatory pain in mice induces light cycle-dependent effects on sleep architecture." bioRxiv : the preprint server for biology 2024.08.28.610124. 29 Aug. 2024, doi:10.1101/2024.08.28.610124. Preprint. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Muller Cell (Cat#: NCL2110P040)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)